Portal:CPTAC
From WikiPathways
| Line 9: | Line 9: | ||
}} | }} | ||
| - | <div style="float:left; width: | + | <div style="float:left; width:68%"> <!-- This width add to the the margin below to equal 99%--> |
| + | |||
{{{{FULLPAGENAME}}/box-normal | {{{{FULLPAGENAME}}/box-normal | ||
|<!-- TITLE OF BOX --> | |<!-- TITLE OF BOX --> | ||
| Line 22: | Line 23: | ||
</div> | </div> | ||
| - | <div style="float:right; width: | + | <div style="float:right; width:31%"> <!-- This margin should be right of the above --> |
{{{{FULLPAGENAME}}/box-normal | {{{{FULLPAGENAME}}/box-normal | ||
Revision as of 18:04, 3 October 2017
CPTAC Pathways
Welcome to the CPTAC Pathway PortalThis portal highlights pathway content relevant to the Clinical Proteomic Tumor Analysis Consortium (CPTAC). The National Cancer Institute, part of the National Institutes of Health, announced the launch of a Clinical Proteomic Tumor Analysis Consortium in August 2011. CPTAC is a comprehensive and coordinated effort to accelerate the understanding of the molecular basis of cancer through the application of robust, quantitative, proteomic technologies and workflows. The overarching goal of CPTAC is to improve our ability to diagnose, treat and prevent cancer. To achieve this goal in a scientifically rigorous manner, the NCI launched CPTAC to systematically identify proteins that derive from alterations in cancer genomes and related biological processes, and provide this data with accompanying assays and protocols to the public. The pathways included in this portal have been organized into classic cancer hallmark categories, based on the different biological capabilities acquired during the multistep development of human tumors. To read more, see Hallmarks of cancer: the next generation, Hanahan and Weinberg, Cell 2011. | 
|
Cancer Hallmark Categories
| Sustaining proliferative signaling
MET in type 1 papillary renal cell carcinoma (Homo sapiens) Image does not exist MET in type 1 papillary renal cell carcinoma | Evading growth suppressors
Tumor suppressor activity of SMARCB1 (Homo sapiens) Image does not exist Tumor suppressor activity of SMARCB1 | Activating invasion and metastasis
Neural crest cell migration in cancer (Homo sapiens) Image does not exist Neural crest cell migration in cancer |
| Enabling replicative immortality
Notch signaling (Homo sapiens) Image does not exist Notch signaling | Inducing angiogenesis
PDGF pathway (Homo sapiens) Image does not exist PDGF pathway | Resisting cell death
Apoptosis (Homo sapiens) Image does not exist Apoptosis |
| Deregulating cellular energetics
Fatty acid beta-oxidation (Homo sapiens) Image does not exist Fatty acid beta-oxidation | Genome instability and mutation
Methylation pathways (Homo sapiens) Image does not exist Methylation pathways | Tumor promoting inflammation
Cytokines and inflammatory response (Homo sapiens) Image does not exist Cytokines and inflammatory response |
| Avoiding immune destruction
Interferon type I signaling (Homo sapiens) Image does not exist Interferon type I signaling | Therapeutics
Fluoropyrimidine activity (Homo sapiens) Image does not exist Fluoropyrimidine activity |
Featured Pathways
|
Image does not exist PDGFR-beta pathway Zhang, et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer |
| View featured pathways |
| List of all pathways for this portal |
Pathway Curation
On this page you see rotating displays of hallmark and featured pathways. Where did these pathways come from? They came from people like you! The CPTAC set of pathways can be edited, fixed and added to using the pathway drawing and annotation tools here at WikiPathways.
Getting Started
- Introduction to WikiPathways (slides)
- WikiPathways Overview or New Contributor Quickstart
- General help pages
- CPTAC Workshop Exercises
Resources
- Learn more about CPTAC
- Pathway analysis
- Cytoscape and the WikiPathways app
- PathVisio and the WikiPathways plugin
Curation projects
- Curating Hallmark Pathways -- How to
- Example: construction of Pathways in Renal Cancer
- Contact Alex Pico if interested in curating, adding or using CPTAC pathways, apico@gladstone.ucsf.edu
